Industry News
Many skin cancers driven by ultraviolet light-induced mutation
Sep 10, 2014
A genetic mutation caused by ultraviolet light is likely the driving force behind millions of human skin cancers, according to researchers at the Stanford University School of Medicine. Read More
Popular cancer drug target implicated in cardiovascular defects
Sep 10, 2014
Research led by UNC's Kathleen Caron, Ph.D., shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development. Read More
Combined therapy improves survival for patients with liver cancer who are not suitable for surgery
Sep 10, 2014
The mature results from a trial conducted by the Asia-Pacific Hepatocellular Carcinoma Trials Group led by the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) have shown... Read More
Prediabetes increases the risk of cancer by 15 percent
Sep 10, 2014
A meta-analysis comprising 16 studies and 891,426 participants from various regions of the world shows that prediabetes increases the risk of cancer by 15%, with differing risks depending on the type... Read More
Immune cells use two critical receptors to clear dead cells from the body, pointing the way to new autoimmune and cancer therapies
Sep 10, 2014
In most of the tissues of the body, specialized immune cells are entrusted with the task of engulfing the billions of dead cells that are generated every day. Read More
New genetic target for a different kind of cancer drug should benefit lung and breast cancer patients
Sep 10, 2014
Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast... Read More
Platelet-like particles augment natural blood clotting
Sep 10, 2014
A new class of synthetic platelet-like particles could augment natural blood clotting for the emergency treatment of traumatic injuries - and potentially offer doctors a new option for curbing... Read More
New guideline created for managing sickle cell disease
Sep 09, 2014
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many... Read More
HPV vaccination program in Australia leads to 61 percent fall in female genital warts
Sep 09, 2014
GPs in Australia are managing 61 per cent less cases of genital warts among young women since the introduction of the national human papillomavirus (HPV) vaccination program, a new study from the... Read More
Enzalutamide significantly reduces morbidities associated with bone metastases in men with metastatic castration-resistant prostate cancer
Sep 09, 2014
Enzalutamide (XTANDI™) reduces the risk of skeletal-related events compared with placebo, as well as reducing pain and increasing quality of life in men with metastatic castration-resistant... Read More
Previous Page Next Page